Boston University School of Medicine

Summary

Boston University School of Medicine is a medical facility located in Boston, Massachusetts. This center is recognized for care of Alzheimer's Disease, Systemic Sclerosis, Pulmonary Arterial Hypertension, Pulmonary Hypertension, Asthma and other specialties. Boston University School of Medicine is involved with conducting 124 clinical trials across 169 conditions. There are 3 research doctors associated with this hospital, such as Marcin Trojanowski, MD, Monica Crespo-Bosque, and Ann M Rasmusson, MD.

Top PIs

Clinical Trials running at Boston University School of Medicine

Henoch-Schonlein Purpura

Microscopic Polyangiitis

Anaphylactoid Syndrome

Multiple Myeloma

Eosinophilic Granulomatosis with Polyangiitis

Granulomatosis with Polyangiitis

Giant Cell Arteritis

Takayasu Arteritis

Noninfectious Panuveitis

Churg-Strauss Syndrome

Tissue Collection

for Vasculitis

The purpose of this study is to collect existing tissue specimens from subjects enrolled in Vasculitis Clinical Research Consortium (VCRC) studies. Analysis of these tissue specimens and linked clinical data collected through VCRC studies may lead to the identification and development of a series of translational research projects. Results of these studies will provide vasculitis researchers with insight into the causes of these diseases and generate new ideas for diagnostic tests and therapies, and will be of great interest to the larger communities of researchers investigating vasculitis and other autoimmune, inflammatory, and vascular diseases.

Recruiting

1 award

N/A

1 criteria

Clinical Transcriptomics

for Vasculitis

Multi-center observational study to evaluate the histopathology and transcriptome of cutaneous lesions in patients with several different types of vasculitis.

Recruiting

1 award

N/A

10 criteria

Treatments Comparison

for Skin Vasculitis

This trial is testing three different drugs to find the best treatment for patients with isolated skin vasculitis. The drugs help by reducing inflammation and controlling the immune system.

Recruiting

1 award

Phase 2

8 criteria